Novel suppressive effects of ketotifen on migration and invasion of MDA-MB-231 and HT-1080 cancer cells

Hyun Ji Kim, Mi Kyung Park, Soo Youl Kim, Chang Hoon Lee

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

The high mortality rates associated with cancer reflect the metastatic spread of tumor cells from the site of their origin. Metastasis, in fact, is the cause of 90% of cancer deaths. Therefore, considerable effort is being made to inhibit metastasis. In the present study, we screened ketotifen for anti-migratory and anti-invasive activities against MDA-MB-231 breast cancer and HT-1080 fibrosarcoma cancer cells. Cancer cell migration and invasion were measured using multi-well chambers. Additionally, western blots were used to examine the effects of ketotifen on the expressions of CDC42, Rho, Rac, and matrix metalloproteinase 9 (MMP-9). The results showed that ketotifen dose-dependently suppressed the migration and invasion of MDA-MB-231 and HT-1080 cells. Ketotifen also suppressed the expressions of CDC42, Rac, and Rho, which, significantly, are involved in MDA-MB-231 and HT- 1080 cancer cell migration. Moreover, ketotifen suppressed the expression and activity of MMP-9, which is involved in degradation of the extracellular matrix leading to invasion. The overall data suggested that ketotifen suppresses the migration and invasion of MDA-MB-231 and HT-1080 cancer cells via inhibition of CDC42, Rac, Rho, and MMP-9 expression.

Original languageEnglish
Pages (from-to)540-546
Number of pages7
JournalBiomolecules and Therapeutics
Volume22
Issue number6
DOIs
StatePublished - 1 Nov 2014

Keywords

  • HT-1080
  • Invasion
  • Ketotifen
  • MDA-MB-231
  • Migration

Fingerprint

Dive into the research topics of 'Novel suppressive effects of ketotifen on migration and invasion of MDA-MB-231 and HT-1080 cancer cells'. Together they form a unique fingerprint.

Cite this